Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03231735 · ClinicalTrials.gov registry record · Phase 2
Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome
A Phase 2 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT03231735 is a Phase 2 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants.
The verdict
NCT03231735, a Phase 2 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine, in preterm infants less than 37 weeks gestation with respiratory distress who are ventilated in the first 48 hours after birth, if mid frequency ventilation strategy using ventilator rate of ≥ 60 to ≤ 150 per minute compared with standard frequency ventilation strategy using ventilator rates of ≥ 20 to \< 60 per minute will increase the number of alive ventilator-free days after randomization and reduce the risk of ventilator induced lung injury.
Interventions
- DEVICE Mid frequency ventilation
- DEVICE Standard frequency ventilation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-08-02 |
| Est. Completion | 2024-10-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03231735
The ClinicalTrials.gov registry entry for NCT03231735 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mid frequency ventilation is the first listed.
NCT03231735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03231735 about?
NCT03231735 is a clinical study titled "Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome". The purpose of this study is to determine, in preterm infants less than 37 weeks gestation with respiratory distress who are ventilated in the first 48 hours after birth, if mid frequency ventilation strategy using ventilator rate of ≥ 60 to ≤ 150 per minute compared with standard frequency ventilat...
What is the current status of trial NCT03231735?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2017-08-02. Estimated completion is 2024-10-10.
What interventions are being tested in trial NCT03231735?
The interventions under investigation include: Mid frequency ventilation (DEVICE), Standard frequency ventilation (DEVICE).
Who is sponsoring clinical trial NCT03231735?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.